OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
044820$22650.0058

Cosmax BTI Inc

Food ProcessingVerified

The company's capital structure is characterized by a high debt-to-equity ratio of 1.87, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 0.56, suggesting limited short-term liquidity. The price-to-book ratio of 0.79 and price-to-tangible-book ratio of 0.79 indicate that the company's market value is below its book value, which may reflect market skepticism about its intangible assets or future earnings potential. In terms of profitability, Cosmax BTI Inc reports a return on equity (ROE) of 10.6% and a return on assets (ROA) of 2.9%. These figures are below the industry median for ROE and ROA in the Food Processing sector, suggesting that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is derived from two segments: Health Functional Food and Other. The Health Functional Food segment is the primary revenue driver, with the Other segment also contributing to the company's overall performance. However, the company's geographic exposure is concentrated in Korea, and there is no indication of significant international operations or revenue diversification. The company's growth trajectory is mixed. While the current fiscal year is expected to see a revenue increase to 1,632,987,000,000 KRW, the capital expenditure of -30,608,524,520 KRW suggests a reduction in investment in physical assets. This may indicate a strategic shift towards cost optimization or a focus on maintaining existing operations rather than expanding. The risk assessment for Cosmax BTI Inc highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could pose challenges in meeting short-term obligations. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving the value of existing shareholders' equity. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's focus remains on its core segments, and there are no significant new developments in its business model or market position.

30-day price · 044820+4390.00 (+27.9%)
Low$15010.00High$23700.00Close$20150.00As of12 May, 00:00 UTC
Profile
CompanyCosmax BTI Inc
Ticker044820.KS
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Cosmax BTI Inc is a Korea-based company engaged in the manufacture and sale of health functional foods and pharmaceutical and cosmetic raw materials.

Classification. Cosmax BTI Inc is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry with a confidence level of 0.92.

The company's capital structure is characterized by a high debt-to-equity ratio of 1.87, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 0.56, suggesting limited short-term liquidity. The price-to-book ratio of 0.79 and price-to-tangible-book ratio of 0.79 indicate that the company's market value is below its book value, which may reflect market skepticism about its intangible assets or future earnings potential. In terms of profitability, Cosmax BTI Inc reports a return on equity (ROE) of 10.6% and a return on assets (ROA) of 2.9%. These figures are below the industry median for ROE and ROA in the Food Processing sector, suggesting that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is derived from two segments: Health Functional Food and Other. The Health Functional Food segment is the primary revenue driver, with the Other segment also contributing to the company's overall performance. However, the company's geographic exposure is concentrated in Korea, and there is no indication of significant international operations or revenue diversification. The company's growth trajectory is mixed. While the current fiscal year is expected to see a revenue increase to 1,632,987,000,000 KRW, the capital expenditure of -30,608,524,520 KRW suggests a reduction in investment in physical assets. This may indicate a strategic shift towards cost optimization or a focus on maintaining existing operations rather than expanding. The risk assessment for Cosmax BTI Inc highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could pose challenges in meeting short-term obligations. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving the value of existing shareholders' equity. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's focus remains on its core segments, and there are no significant new developments in its business model or market position.
Key takeaways
  • Cosmax BTI Inc has a high debt-to-equity ratio, indicating a significant reliance on debt financing.
  • The company's ROE and ROA are below the industry median, suggesting underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated in two segments, with a primary focus on health functional foods.
  • The company is expected to see revenue growth in the current fiscal year, but capital expenditure is negative, indicating a reduction in investment.
  • The company faces medium liquidity risk and low dilution risk, with a negative net cash position after subtracting total debt.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$645.21B
Gross profit$135.51B
Operating income$22.98B
Net income$29.21B
R&D
SG&A
D&A
SBC
Operating cash flow$35.17B
CapEx-$30.61B
Free cash flow$11.34B
Total assets$1.01T
Total liabilities$730.80B
Total equity$275.54B
Cash & equivalents$99.43B
Long-term debt$513.95B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$22650.00
Market cap$216.42B
Enterprise value$630.93B
P/E7.4
Reported non-GAAP P/E
EV/Revenue1.0
EV/Op income27.5
EV/OCF17.9
P/B0.8
P/Tangible book0.8
Tangible book$275.54B
Net cash-$414.52B
Current ratio0.6
Debt/Equity1.9
ROA2.9%
ROE10.6%
Cash conversion1.2%
CapEx/Revenue-4.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
Metric044820Activity
Op margin3.6%3.3% medp25 2.5% · p75 4.5%above median
Net margin4.5%3.0% medp25 1.5% · p75 6.7%above median
Gross margin21.0%24.0% medp25 20.2% · p75 35.3%below median
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-4.7%5.2% medp25 4.8% · p75 5.7%bottom quartile
Debt / equity187.0%33.5% medp25 29.1% · p75 81.5%top quartile
Observations
IR observations
Mean EPS estimate8,569.97 KRW
Mean revenue estimate1,632,987,000,000 KRW
Mean EBIT estimate102,625,000,000 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:23 UTC#c26c0c46
Market quoteclose KRW 22650.00 · shares 0.01B diluted
no public URL
2026-05-10 12:23 UTC#c6a3323e
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:25 UTCJob: 3e5d66fa